IP Library Granted Patent US 10,010,440
Granted Patent B2
US 10,010,440 · App. 14/699,911 · Granted Jul 3, 2018

Intragastric balloon system

Inventors: Owen Shawn Sobelman (Shingle Springs, CA); Janel A. Birk (Oxnard, CA)
Assignee: APOLLO ENDOSURGERY US, INC.
A61F5/003A61F5/0036A61M29/02A61M39/26A61M2039/0036
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,010,440
App. No.
14/699,911
Granted
Jul 3, 2018
Kind
B2
Abstract

A system includes a slit valve for use with an inflatable intragastric balloon having a flange surface with an opening therein. The slit valve has a valve body connected to the flange surface and a chamber formed in the valve body. The system also includes a filler tube, that is accepted into the chamber when it is inserted through the opening in the flange surface.

Claims (16)

1. An inflatable medical system, comprising:

an inflatable implant formed of a flexible polymer material suitable for residence in the body;

a slit valve provided in a wall of the flexible polymer material comprising an elastomeric valve body defining a proximal end and a distal end, the proximal end of the valve body having a proximal opening therein surrounded by a flange, an open internal chamber formed within the valve body being in open fluid communication with the proximal opening, the internal chamber having a concave section at its distal end, and a normally closed slit formed in a portion of the valve body connecting the concave section of the internal chamber and the distal end of the valve body; and

a filler tube having a lumen therethrough, the filler tube defining an injection tip having a distal end, the injection tip further including an insertion stop located proximal to the distal end of the injection tip, and a reduced diameter portion located between the distal end of the injection tip and the insertion stop, the distal end of the injection tip comprising a tapered portion, the reduced diameter portion having an outer diameter smaller than an outer diameter of a distal end of the insertion stop and smaller than an outer diameter of a proximal end of the tapered portion,

wherein the elastomeric valve body is configured to receive the filler tube through the proximal opening such that fluid may be introduced into the internal chamber and, at a threshold fluid pressure differential across the slit, open the slit and pass fluid distally through the slit and into the inflatable implant, and

wherein the insertion stop is sized to positively engage and form a seal with the proximal opening, and limit a distance to which the injection tip extends into the internal chamber, at which distance the distal end of the injection tip is sized to form a first fluid seal with a portion of the internal chamber and remains spaced proximally from the concave section, and at which distance a second seal is formed by an interference of the flange and the reduced diameter portion of the injection tip, wherein when the second seal is formed, the flange is retained between the insertion stop and the distal end of the injection tip and prevents the injection tip from separating from the slit valve when fluid pressure in the internal chamber is at the threshold fluid pressure differential across the slit.

2. The system of claim 1 , wherein the distal end of the injection tip is wedge shaped.

3. The system of claim 1 , wherein at least a portion of the internal chamber substantially conforms to the tapered portion of the injection tip.

4. The system of claim 1 , wherein at least a portion of the internal chamber substantially conforms to at least a portion of the injection tip of the filler tube.

5. The system of claim 1 , wherein the filler tube includes a flexible tube and the injection tip is a rigid piece.

6. The system of claim 1 , wherein the internal chamber includes a proximal first region immediately adjacent the proximal opening and a distal second region in open fluid communication with the first region.

7. The system of claim 6 , wherein the concave section is located at a distal end of the second region, and wherein the internal chamber in the valve body narrows between the first and second regions to form a neck that defines the portion of the internal chamber that forms the first fluid seal with the distal end of the injection tip.

8. The system of claim 6 , wherein the concave section is located at a distal end of the second region, and wherein the internal chamber in the valve body narrows between the first and second regions defining a neck when the injection tip is positioned within the first region of the internal chamber to form the first fluid seal.

9. The system of claim 6 , wherein the distal end of the valve body defines a second concave section such that the slit connects the concave section of the second region and the second concave section.

10. The system of claim 1 , wherein the inflatable implant is an intragastric implant and the flexible polymer material is suitable for residence in the stomach.

11. The system of claim 1 , wherein the inflatable implant is a gastric balloon and the flexible polymer material is suitable for residence in the stomach.

Assignments (11)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2023
From: APOLLO ENDOSURGERY US, INC.
To: APOLLO ENDOSURGERY, INC.
Reel/Frame 066128/0655 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2023
From: APOLLO ENDOSURGERY, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 066128/0812 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 5, 2023
From: APOLLO ENDOSURGERY, INC.; APOLLO ENDOSURGERY US, INC.; APOLLO ENDOSURGERY INTERNATIONAL, LLC; LPATH THERAPEUTICS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 063264/0046 →
RELEASE OF SECURITY INTEREST Recorded Dec 30, 2021
From: SLR INVESTMENT CORP. (F/K/A SOLAR CAPITAL LTD.)
To: APOLLO ENDOSURGERY US, INC.; APOLLO ENDOSURGERY INTERNATIONAL, LLC; APOLLO ENDOSURGERY, INC.; LPATH THERAPEUTICS INC.
Reel/Frame 058599/0297 →
SECURITY INTEREST Recorded Dec 23, 2021
From: APOLLO ENDOSURGERY, INC.; APOLLO ENDOSURGERY US, INC. (F/K/A LPATH, INC.)
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 058980/0199 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 15, 2019
From: APOLLO ENDOSURGERY US, INC.
To: SOLAR CAPITAL LTD., AS COLLATERAL AGENT
Reel/Frame 048885/0687 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Mar 18, 2019
From: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
To: APOLLO ENDOSURGERY US, INC. (F/K/A APOLLO ENDOSURGERY, INC.)
Reel/Frame 048622/0328 →
CHANGE OF NAME Recorded Mar 27, 2017
From: APOLLO ENDOSURGERY, INC.
To: APOLLO ENDOSURGERY US, INC.
Reel/Frame 042106/0912 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Dec 30, 2016
From: APOLLO ENDOSURGERY US, INC.
To: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
Reel/Frame 041224/0821 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2015
From: SOBELMAN, OWEN SHAWN; BIRK, JANEL A.
To: ALLERGAN, INC.
Reel/Frame 035533/0111 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2015
From: ALLERGAN, INC.
To: APOLLO ENDOSURGERY, INC.
Reel/Frame 035533/0276 →
Continuity (4)
Division 13667617 · Nov 2, 2012
Division 12785710 · May 24, 2010
Continuation 10561515
Related Publication 20150230956A1 · Aug 20, 2015